» Articles » PMID: 14751760

Toll-like Receptors and Acquired Immunity

Overview
Journal Semin Immunol
Date 2004 Jan 31
PMID 14751760
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Toll-like receptors are a family of pattern recognition receptors (PRRs) that evolved to detect microbial infection. These receptors recognize conserved molecular products derived from different classes of microorganisms, including Gram-positive and -negative bacteria, fungi, protozoa and viruses. Following recognition of ligands TLRs initiate signaling events that result in acute innate responses. In addition, TLRs are responsible for initiation of adaptive immune responses against pathogen-derived antigens primarily through triggering dendritic cell activation. Control of adaptive immunity by TLRs is a complex phenomenon and much needs to be understood about how different TLRs tailor the outcome of adaptive immune responses to the advantage of the host. Although TLRs have evolved to induce protective immune responses, under some circumstances, activation of these receptors may lead to autoimmune diseases.

Citing Articles

The Modification of H3K4me3 Enhanced the Expression of TLR3 in Hemocytes to Increase IL17-1 Production in the Immune Priming of .

Lian X, Li Y, Wang W, Zuo J, Yu T, Wang L Int J Mol Sci. 2024; 25(2).

PMID: 38256110 PMC: 10816183. DOI: 10.3390/ijms25021036.


Superior Efficacy of Apathogenic Genotype I (V4) over Lentogenic Genotype II (LaSota) Live Vaccines against Newcastle Disease Virus Genotype VII.1.1 in Pathogen-Associated Molecular Pattern-H9N2 Vaccinated Broiler Chickens.

Elbestawy A, Ellakany H, Sedeik M, Gado A, Abdel-Latif M, Noreldin A Vaccines (Basel). 2023; 11(11).

PMID: 38005970 PMC: 10674370. DOI: 10.3390/vaccines11111638.


Ghosts as a Vehicle for the Delivery of DNA Vaccines Mediate Immune Responses.

Yu X, Wang L, Yang X, Zhang S, Li G, Zhang L Front Immunol. 2022; 13:849409.

PMID: 35711427 PMC: 9193971. DOI: 10.3389/fimmu.2022.849409.


Hallmarks of Resistance to Immune-Checkpoint Inhibitors.

Karasarides M, Cogdill A, Robbins P, Bowden M, Burton E, Butterfield L Cancer Immunol Res. 2022; 10(4):372-383.

PMID: 35362046 PMC: 9381103. DOI: 10.1158/2326-6066.CIR-20-0586.


Microbial Colonization and Inflammation as Potential Contributors to the Lack of Therapeutic Success in Oral Squamous Cell Carcinoma.

Kurago Z, Loveless J Front Oral Health. 2022; 2:739499.

PMID: 35048056 PMC: 8757816. DOI: 10.3389/froh.2021.739499.